Stockreport

Acorda to Present Data for INBRIJA™ (levodopa inhalation powder) at 2nd Pan American Parkinson’s Disease and Movement Disorders Congress

Acorda Therapeutics, Inc.  (ACOR) 
Last acorda therapeutics, inc. earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: acorda.com/investors
PDF ARDSLEY, N.Y.--(BUSINESS WIRE)-- Acorda Therapeutics, Inc. (Nasdaq: ACOR) will present four encore INBRIJA posters at the upcoming 2nd Pan American Parkins [Read more]